Contact
DMCA
Privacy
Robuta
https://pubmed.ncbi.nlm.nih.gov/35416908/
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate...
ClinicalTrials.gov Identifier: NCT03073200.
long term
up to
efficacy
safety
weeks
https://www.ncbi.nlm.nih.gov/books/NBK548925/
Ixekizumab - LiverTox - NCBI Bookshelf
Ixekizumab is a humanized monoclonal antibody to interleukin-17A which acts as an antiinflammatory agent and is used to treat moderate-to-severe plaque...
ncbi bookshelf
ixekizumab
livertox